Natco Pharma Q4 net profit down 60% at Rs 120 crore; FY19 income dips

Natco Pharma Limited reported on Monday a 60 per cent decline in consolidated net profit at Rs 120.4 crore for the quarter ended March 2019 (Q4) due to a fall in revenues, as compared to Rs 299.7 crore in the corresponding quarter previous year.

Natco Pharma revenues decreased by 38 per cent to Rs 486.7 crore in Q4, compared to Rs 787.9 crore in the year-ago period. 

For the full year ended March 2019 (FY19), the company's consolidated net profit stood at Rs 642.4 crore, a decrease of 7.6 percent from Rs 695.2 crore in the previous financial year (FY18).